Company intelligence / Profile preview

Hurone AI

Seattle, Washington, United Stateshurone.ai ↗

Ownership: Private
Development stage: Commercial

Overview

Hurone AI’s platforms have demonstrated improved patient engagement and provider workflow efficiency in pilot programs with breast cancer patients in Rwanda. The company has received positive feedback from clinicians and patients alike. Its technology has been recognized by the White House Cancer Moonshot initiative and AWS as an example of innovation increasing access to cancer care in Africa.

Therapeutic areas: OncologyEndocrinology
Modalities: Non-pharmacological therapy (AI-driven digital health platform)
Industry: Digital Health Medical Devices

Partnerships

AWS/Amazon Web Services Health Equity Initiativepartnerships with top cancer centers globally

Beyond the preview

Go deeper on Hurone AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hurone AI.

Explore the full profile